Cosmetic Services

Agreement
144 Research Drive, Hampton, Virginia, 23666, USA for U.S. Companies
P: +1-757-224-0177 F: +1-757-224-0179 E: info@registrarcorp.com

AGREEMENT by and between Registrar Corp ("Registrar") and

Legal Company Name:

(include corporate designation such as SARL, S.A., BV, Ltd., etc.)

Company Address:

("Company").

Subject to the terms and conditions of this Agreement, the Modernization of Cosmetics Regulation Act of 2022 ("MoCRA") and any
related implementing regulations thereto, the parties agree that Registrar shall advise and assist Company as its authorized agent in
connection with certain services. The specific services that Registrar will perform for the Company are listed on the attached order form
and may include one or more of the following: (i) filing facility registration(s) with the U.S. Food & Drug Administration ("FDA"), (ii)
listing with the FDA only those of Company's cosmetic products that Company properly inputs into forms (e.g. on Company's MyFDA
account) provided by Registrar, or (iii) providing Company with Adverse Event Contact services.
1. Company will provide Registrar with all information, materials, and fees necessary or reasonably requested by Registrar to fulfill
Registrar's responsibilities hereunder. Additionally, Company shall inform Registrar immediately of any information required to be
reported to the FDA, including but not limited to, updates and/or changes to facility registration(s) and product listing(s) information.
Company warrants that the information and materials provided by Company will be accurate, truthful, genuine, and current. If
permitted by the implementing regulations of MoCRA, Company authorizes the employees of Registrar to submit information to the
FDA, including facility registration(s) and product listing(s) information, any necessary or prudent updates thereof, and such other
information as Registrar believes necessary or prudent for Company to submit. If applicable, Registrar may assist Company with
flexible product listing(s). Registrar is not responsible for any rejections, resubmissions, or listing submission errors resulting from
inaccurate or incorrect information provided by Company. Registrar has the right to refuse submission of any product listing.

2. If the service described under (iii) above is listed on the attached order form, and consistent with Section 609(a) of MoCRA, Company
may list the Adverse Event Contact (as defined herein) on its product package(s) and label(s), but only on those specific product
package(s) or label(s) for which Company has properly provided the corresponding product listing(s) for each package or label to
Company's MyFDA account ("Applicable Labels"). The "Adverse Event Contact" is the address or electronic contact information
generated by Registrar Corp and provided to Company. Company must use the Adverse Event Contact as generated by Registrar
without any modification. If Company applies the Adverse Event Contact to any package or label that is not an Applicable Label or
if the Adverse Event Contact is modified on any of Company's packages or labels from the version generated by Registrar, Registrar
may, in its sole and absolute discretion, terminate its Adverse Event Contact service for any such package or label. Company
acknowledges that such termination may result in fines, penalties, and similar negative consequences (e.g. misbranding) for the
product(s) still bearing the Adverse Event Contact. Company shall be identified as the responsible person on each product label
bearing the Adverse Event Contact, and Company shall be responsible for any and all actions or inaction in connection with its
product(s) or reports of adverse events.

3. This Agreement is not intended to benefit any third party or non-party, and nothing contained herein shall be construed as creating
any right, claim, cause of action, or benefit to any person except Company and Registrar. To the extent Registrar is determined to be
an agent of Company in connection with Company's product(s), adverse events, reports of adverse events, or any other matter
hereunder, Company shall perform such steps as may be required to identify itself as a disclosed principal of Registrar.

4. The services performed by Registrar under this Agreement are limited strictly to those listed herein. Unless a separate agreement for
such services is executed in writing by all parties, Registrar shall not assist nor be responsible for Company's compliance with any
other requirements of the FDA or U.S. law or regulations, including but not limited to, services related to labeling, product
classification (e.g. whether a product constitutes a cosmetic), suspensions, recalls, reporting to the FDA of serious adverse events,
including fragrance and/or flavor ingredients that may be related to a serious adverse event, or corrections and removals related to any
of the foregoing. Company represents and warrants it shall conduct such obligations and report any such events to the FDA without
Registrar's assistance. For the avoidance of doubt, Registrar Corp has no responsibility hereunder related to the obligations set forth
in Section 605 of MoCRA.

Page 1 of 2
 Cosmetic Services
Agreement
144 Research Drive, Hampton, Virginia, 23666, USA for U.S. Companies
P: +1-757-224-0177 F: +1-757-224-0179 E: info@registrarcorp.com

5. The fee shall be paid in accordance with Registrar's standard fee schedule and any modifications or revisions thereto. Registrar may
perform additional services in its discretion at Company's request for additional fees. Registrar does not and will not practice law or
render legal advice.

6. Company agrees to reimburse, indemnify and hold harmless Registrar from and against any and all expenses, costs and claims,
including but not limited to claims by third parties and nonparties, including but not limited to any governmental agencies, and related
costs and attorneys’ fees, whether such claims are alleged in tort, contract or under federal, state, or other law, related to or arising out
of Company's products, adverse or serious adverse events, reports of adverse or serious adverse events, this Agreement, any
termination of this Agreement or any termination of an Adverse Event Contact service, the transactions contemplated hereby, any
claim connected to the business or operations of Company, or any breach of law by Company. Company waives any and all claims
against Registrar arising out of or in connection with this Agreement except for willful misconduct or gross negligence and for those
waives its claims to the extent the law permits. This waiver expressly includes, without limitation, any and all claims and fines related
to or arising out of a finding by the FDA of misbranding or adulteration. Registrar makes no representations except those set forth
herein and does not warrant or guarantee any specific result. As used in this Agreement, “Registrar” shall include Registrar Corp, its
successors, assigns, affiliates, parents, subsidiaries, officers, directors, shareholders, agents and employees.

7. Neither party to this contract shall be held responsible for breach of contract caused by an act of God, insurrection, civil war, war,
military operation, terrorism or local emergency, or by any act or failure to act by the FDA. Time shall not be of the essence for
services to be rendered by Registrar. This Agreement, together with the documents attached hereto and incorporated herein by
reference, contains the entire agreement between the parties, and may not be modified except by written agreement executed by both
parties.

8. This Agreement shall be construed, and the legal relations between the parties determined, in accordance with the laws of the State of
New York, without giving effect to its choice of law provisions. Any action or proceeding arising out of or in connection with this
Agreement or the transactions contemplated hereby shall be brought in the courts of New York or the U.S. District Courts for the
Southern or Eastern Districts of New York. The parties hereto consent to exercise of in personam and subject matter jurisdiction by
the courts of the State of New York, and the U.S. District Courts for the Southern or Eastern Districts of New York.

9. Registrar may, in its sole and absolute discretion, terminate this Agreement at any time upon giving written notice to Company by
U.S. Mail to the address stated above or provided by Company for its facility registration(s), or by e-mail to the e-mail address
provided by Company for its facility registration(s). Company may terminate this Agreement at any time by FedEx, DHL, or UPS
overnight delivery service to Registrar, with such information as will confirm that Company's facility registration(s) has been
maintained or canceled consistent with the requirements of MoCRA. In the event of termination by either party, no part of the fees
paid to Registrar hereunder shall be refunded. Unless terminated earlier pursuant to this paragraph, the Agreement will commence
upon receipt of payment from Company and will continue in full force and effect until December 31, 2024, and thereafter, shall renew
automatically for successive terms of one year beginning on each successive January 1st.

10. Company acknowledges that Registrar is a private registration agent not affiliated with the FDA. The person signing below represents
and warrants that he/she is an owner, officer, or employee of the Company with authority to make binding commitments on behalf of
the Company.

By: Title:
(Signature) (For example: President, Vice President, General Manager, etc.)
Contact Phone:___________________________________ Contact Email:

Print Name: Date:

If you have questions, please contact Client Solutions by phone: 757-224-0177 or email: info@registrarcorp.com

Page 2 of 2